Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06530225Not Yet Recruiting

Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program

Role: collaborator

NCT03818659Not ApplicableCompleted

Improving BP Control in Diverse Populations Using BP MAP

Role: collaborator

NCT06214806Not ApplicableCompleted

Food Is Medicine: Makin' Healthy Groceries

Role: collaborator

NCT05548803Completed

COVID-19 Citizen Science Expansion Project

Role: collaborator

NCT03591107Not ApplicableCompleted

Trauma-informed Collaborative Care for Low-income African Americans With PTSD

Role: collaborator

NCT05185232Unknown

Congenital Heart Initiative-Redefining Outcomes and Navigation to Adult Centered Care

Role: collaborator

NCT03743493Completed

PCORnet Opioid Surveillance Study

Role: lead

All 7 trials loaded